Aurobindo Pharma Limited has informed the Exchange about Copy of Newspaper Publication
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aurobindo Pharma has published a notice in Business Standard and Nava Telangana (Telugu) on July 23, 2025, informing shareholders about a special window for re-lodging physical share transfer requests. This follows a SEBI circular dated July 2, 2025, and applies to transfer deeds that were lodged before April 1, 2019, but were rejected, returned, or not processed due to document deficiencies. Eligible shareholders must approach the company's Registrar and Transfer Agent, KFin Technologies Limited, by January 6, 2026. All re-lodged securities will be issued only in demat mode, so shareholders must have a demat account and provide a Client Master List along with original documents and share certificates.
This is a routine regulatory compliance filing and does not affect the company's business operations or financial performance. Shareholders holding physical shares with pending or rejected transfer requests from before April 1, 2019, get a one-time chance to get them transferred until January 6, 2026.